I‐Heng Lee

Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care

Susan Olender, Katherine K Perez, Alan S. Go et al. · Clinical Infectious Diseases · 2020 · 171 citations · Full text

Increasing comorbidities in a South Korea insured population‐based cohort of patients with chronic hepatitis B

Hyunwoo Oh, Dae Won Jun, I‐Heng Lee et al. · Alimentary Pharmacology & Therapeutics · 2020 · 45 citations

Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality

Susan Olender, Theresa L. Walunas, Estebán Martínez et al. · Open Forum Infectious Diseases · 2021 · 45 citations · Full text

Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database

Shuji Terai, Amy Buchanan-Hughes, Alvin Wei Tian Ng et al. · Journal of Gastroenterology · 2021 · 26 citations · Full text

Characteristics and Healthcare Costs in the Aging Hepatitis B Population of Japan: A Nationwide Real-World Analysis

Hiroshi Yotsuyanagi, Masayuki Kurosaki, Hiroshi Yatsuhashi et al. · Digestive Diseases · 2021 · 23 citations · Full text